UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

**FORM 10-K/A Amendment No. 1**

 

(X) ANNUAL REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

 

**For the Fiscal Year Ended September30, 2014**

OR

( ) TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

 

For the transition period from **N/A**to **N/A**

Commission File Number: **000-28745**

**Cloud Medical Doctor Software Corporation**

(Name of small business issuer as specifiedin its charter)

**(Formerly National Scientific Corporation)**

  

**Texas**  	 	**86-0837077** 

State of IncorporationIRS Employer Identification No.

** **

**1291 Galleria Drive, Suite 200**

**Henderson, NV 89014**

(Address of principalexecutive offices)

 

**(702) 818-9011**

(Issuer’s telephone number)

 

**Securities registered under Section 12(b)of the Exchange Act:**

**None**

**Securities registered under Section 12(g)of the Exchange Act:**

**Common Stock, $0.01 par value per share**

**(Title of Class)**

** **

 

Indicate by check mark if the registrant is a well-known seasonedissuer, as defined in Rule 405 of the Securities Act. [ ] Yes [ ] No

 

Indicate by check mark if the registrant is not requiredto file reports pursuant to Section 13 or Section 15(d) of the Act. [ ] Yes [ ] No

 

Indicate by check mark whether the registrant (1) has filedall reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirementsfor the past 90 days. Yes [ ] No [ ]

 

Indicate by check mark whether the registrant hassubmitted electronically and posted on its corporate Website, if any, every Interactive Data File required to besubmitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months(or for such shorter period that the registrant was required to submit and post such files).Yes [ ] No [ ]

 

Indicate by check mark if disclosure of delinquentfilers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained,to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III ofthis Form 10-K or any amendment to this Form 10-K. [ ]

Indicate by check mark whether the registrant is alarge accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “largeaccelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the ExchangeAct. (Check one):

 

 

Indicate by check mark whether the registrantis a shell company (as defined in Rule 12b–2 of the Exchange Act). Yes [ ] No [ ]

 

Aggregate market value of the voting stockheld by non-affiliates: $4,234,374 as based on the closing price of the stock on December 18, 2014 (the last business day of theRegistrant’s prior second fiscal quarter). The voting stock held by non-affiliates on that date consisted of 173,995,712shares of common stock.

 

Indicate the number of shares outstandingof each of the registrant’s classes of common stock, as of the latest practicable date. As of December 18, 2014, there were283,473,722 shares of common stock, par value $0.01, issued and outstanding 4,000,000 shares of preferred stock, par value $0.01.

 

**Documents Incorporated by Reference: None**

** **

**EXPLANATORY NOTE**

 

This AmendmentNo. 1 on Form 10-K amends the Annual Report on Form 10-K for the year ended September 30, 2014, filed on January 5, 2015(the “Original Report”) filed by National Scientific Corporation (the “Company”) in response to an internalreview by the company. The Company is amending disclosure in Item 10. Directors, Executive Officers, Promoters and ControlPersons; Compliance with Section 16(a) 16(a) of the Exchange Act. The Company is amending this sectionto provide more detailed disclosure and extended disclosures to provide the shareholder more detailed information related to themanagement in that Pamela Thompson a Director and Chief Financial Officer resigned her positions with the Company after the Form10-K was completed but before it was filed. The signature pages and Item 10 are amended to disclose these changes.

 

**I****tem10. Directors, Executive Officers, Promoters and Control Persons; Compliance with Section 16(a) 16(a) of the Exchange Act.**

** **

**Director and Executive Officer**

 

Set forth below is information regarding the Company’s currentdirectors and executive officers. There are no family relationships between any of our directors or executive officers. The directorsare elected annually by stockholders. The executive officers serve at the pleasure of the Board of Directors.

 

 

The chief executive officer and director andofficer of the Company will hold office until additional members or officers are duly elected and qualified. The background andprincipal occupations of the sole officer and director of the Company is as follows:

 

**Michael De La Garza**

 

Cloud Medical Doctor Software Corporation– 2010-Present. President, CEO, Chairman of the Board,

Card Activation Technology Corporation. -President, CEO, Chairman of the Board a gift card technology company- 2008-2009

MedCom USA, Corporation. -President, CEO, Chairman of the Board of a medicalsoftware company - 2008-2009

 

PayMed USA, LLC President and co-founder ofa medical software company -2003-2012

 

Providers Solution, Corporation. Presidentand co-founder of a medical software company -2000-2012

 

Accident and Injury Medical Centers, Corporation,President and co-founder of a medical rehab company 1993-1999

 

Medical Synergies Corporation. COO, President,a medical billing company. 1991-1999

 

The Center’s for Diagnostic MedicalServices, Corporation. COO and President, a medical imaging group company 1991-1999

 

** **

 

**ITEM 15: SIGNATURES**

** **

**SIGNATURES**

 

In accordance with Section 13 or 15(d) of the Securities ExchangeAct of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.